 |
|
Scientists demonstrate feasibility of preventing malaria parasite from becoming sexually mature
June 03, 2008Discovery could help to control the spread of drug resistance
Researchers have demonstrated the possibility of preventing the human malaria parasite, Plasmodium falciparum, which is responsible for more than a million malaria deaths a year, from becoming sexually mature.
The discovery could have implications for controlling the spread of drug resistance, which is a major public health problem and which hinders the control of malaria.
The life cycle of Plasmodium falciparum is complex, and it is not yet known what triggers the production of parasite gametes or sex cells. These sexual forms of the parasite do not contribute to malaria symptoms, but are essential for transmission of malaria between humans via the bite of a mosquito.
A team based at the London School of Hygiene & Tropical Medicine, working with a colleague from the Wellcome Trust Sanger Institute in Cambridge, identified a parasite enzyme that is instrumental in triggering the emergence of mature gametes within the mosquito. Their findings are published today in the journal PLoS Biology.
Dr. David A Baker, a Reader in Parasite Molecular Biology at the London School of Hygiene & Tropical Medicine and senior author of the study, comments: 'The enzyme we have discovered, a protein kinasea, is essential for the development of malaria parasite gametes. Working with genetically modified parasites, in combination with inhibitors of this enzyme, we have demonstrated that it is feasible to block the sexual stage of the life cycle of the malaria parasite.
He adds: 'This has exciting implications in terms of improving how we go about tackling malaria. If a drug can be developed that targets this stage of the life cycle, and combined with a curative drug, it would be an important new approach for controlling malaria transmission and the spread of drug resistance'.
London School of Hygiene & Tropical Medicine
The life cycle of Plasmodium falciparum is complex, and it is not yet known what triggers the production of parasite gametes or sex cells. These sexual forms of the parasite do not contribute to malaria symptoms, but are essential for transmission of malaria between humans via the bite of a mosquito.
A team based at the London School of Hygiene & Tropical Medicine, working with a colleague from the Wellcome Trust Sanger Institute in Cambridge, identified a parasite enzyme that is instrumental in triggering the emergence of mature gametes within the mosquito. Their findings are published today in the journal PLoS Biology.
Dr. David A Baker, a Reader in Parasite Molecular Biology at the London School of Hygiene & Tropical Medicine and senior author of the study, comments: 'The enzyme we have discovered, a protein kinasea, is essential for the development of malaria parasite gametes. Working with genetically modified parasites, in combination with inhibitors of this enzyme, we have demonstrated that it is feasible to block the sexual stage of the life cycle of the malaria parasite.
He adds: 'This has exciting implications in terms of improving how we go about tackling malaria. If a drug can be developed that targets this stage of the life cycle, and combined with a curative drug, it would be an important new approach for controlling malaria transmission and the spread of drug resistance'.
London School of Hygiene & Tropical Medicine
Malaria Parasite Current Events and Malaria Parasite News RSSSmall nanoparticles bring big improvement to medical imaging
If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging.
PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.
Media availability: The role of biomedical research in malaria eradication
Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year.
UM School of Medicine researchers find extreme genetic variability in malaria parasite
Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world.
New research confirms potential deadly nature of emerging new monkey malaria species in humans
Researchers in Malaysia have identified key laboratory and clinical features of an emerging new form of malaria infection.
Scientists report original source of malaria
Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.
Unique immunization method provides insights about protective anti-malaria immune response
In this week's New England Journal of Medicine, scientists in Singapore, The Netherlands and France report that they have developed a novel immunization method that will induce fast and effective protection in humans against the life-threatening malaria parasite, Plasmodium falciparum, which infects 350 to 500 million people world-wide and kills over one million people each year.
First genetically-engineered malaria vaccine to enter human trials
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease.
Vaccine Blocks Malaria Transmission in Lab Experiments
Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human primates for use in a potential transmission-blocking vaccine.
Breakthrough in combating the side effects of Quinine
Discovered back in the 1600s quinine was the first effective treatment in the fight against malaria - and it continues to be a commonly used treatment against this devastating disease.
More Malaria Parasite Current Events and Malaria Parasite News Articles
 |
Malaria Parasite Biology, Pathogenesis, and Protection by Irwin W. Sherman (Editor) |
 |
Classic Malaria Films DVD: 1940s Malaria Disease Symptoms & Treatments History Films Considered a major epidemic during the 1940's, malaria caused many health and economic problems to Americans. This DVD features two informative films on the life cycle of the mosquitoes that transmit malaria, including information on their breeding places, and the risks they impose to families. Take a close-up look at these pesky insects! Table of Contents: (1) Criminal At Large (1945) - This cartoon from 1945 documents the life cycle of the Anopheles mosquito and the way in which malaria is spread. Cartoons and animated diagrams show the breeding places and life cycle of an Anopheles mosquito and its method of transmitting malaria - 12 Minutes (2) Malaria (1944) - This black and white film is about the origination, transmission, and prevention of malaria. Still pictures show a farm... |
 |
Artemisinin (90 Capsules) Concentrated Herbal Extract - Dietary Supplement by Get Well Natural Get Well Natural LLC's Artemisinin (a sesquiterpene lactone) is the active component isolated from the natural herb Artemisia annua (Qinghaosu) which has been long used in traditional Chinese medicine (TCM) to treat many illnesses such as multi-drug resistant strains of malaria and skin diseases.* This pure form provides a much higher concentration than the whole herb itself making the need to take hundreds of pills obsolete. Research has shown artemisinin to be particularly beneficial in balancing the microbiology of the GI tract.* Additional Information: Artemisinin is currently being used in early research by Henry Lai and Narenda Singh of the University of Washington for its activity against cancer as described in their published paper in Cancer Letters, 1995. *The FDA has not... |
 |
Parasites! - The Malaria Parasite by Sheila Wyborny (Author) Malaria is a serious disease caused by a tiny mosquito-borne parasite called Plasmodium. It once affected entire empires, but thanks to the work of health organizations, malaria is now mostly confined to warm, moist climates. Scientists are still at work today, however, developing methods of curing the disease and destroying its carriers. |
|
Malaria Capers: More Tales of Parasites and People, Research and Reality by Robert S. Desowitz (Author) A realistic study of the present state of research in tropical diseases, this volume examines malaria, which still rages unabated in parts of the world despite over 100 years of medical research, and kala azar, or the black sickness, a disease spread by sand flies which is endemic in India. | |
 |
Malaria Parasites: Genomes and Molecular Biology by Andrew P. Waters (Editor), Chris J. Janse (Editor) |
|
Fighting malaria: the mosquito net vs. the parasite.: An article from: Presbyterian Record by Presbyterian Record (Publisher) This digital document is an article from Presbyterian Record, published by Presbyterian Record on March 1, 1999. The length of the article is 830 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Fighting malaria: the mosquito net vs. the parasite. Publication: Presbyterian Record (Magazine/Journal) Date: March 1, 1999 Publisher: Presbyterian Record Volume: 123 Issue: 3 Page: 1,3 (sup) Distributed by Thomson Gale | |
|
Two monographs on malaria and the parasites of malarial fevers. by Kirtas Books (Author) | |
|
Nature: The International Weekly Journal of Science October 9, 2008; Malaria Parasites b | |
|
Two monographs on malaria and the parasites of malarial fevers / I. Marchiafava and Bignami, II. Mannaberg by Amico (1862-1929). Mannaberg, Juliuss (1860-). Ma New Sydenham Society. Bignami (Author) |
| © 2009 BrightSurf.com |